|
KR20170053432A
|
|
Fast disintegrating vaginal tablet comprising phosphodiesterase-5 inhibitor and a process for the preparation thereof
|
|
KR101695970B1
|
|
Powder containing deferasirox and a process for the preparation thereof
|
|
KR20160081646A
|
|
An oral composite tablet containing melatonin and sertraline
|
|
KR20150107357A
|
|
Process for preparing 8-hydroxyclomipramine or its pharmaceutically acceptable salt
|
|
EP2853263A1
|
|
Multilayer coating form of orally administered pharmaceutical composition containing omega-3 fatty acid or alkyl ester thereof and statin based drug
|
|
KR20140044642A
|
|
Syrup comprising pelargonium sidoides extract and levodropropizine
|
|
KR20130123564A
|
|
PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING ω-3 FATTY ACID OR ITS ALKYL ESTER AND STATIN DRUG
|
|
KR101082802B1
|
|
Pharmaceutical composition for preventing or treating premature ejaculation comprising 8-hydroxyclomipramine or its salt
|
|
KR101136976B1
|
|
Pharmaceutical composition for preventing or treating alopecia comprising tianeptine or its salt
|
|
KR20120138908A
|
|
Entecavir-containing microspheres and process for preparing the same
|
|
KR101069128B1
|
|
Process for preparing pharmaceutical formulation in form of antioxidant-free solution for injection comprising pemetrexed or its salt
|
|
KR20110027879A
|
|
Sustained released tablet containing quetiapine or its salt
|
|
EP1664775A1
|
|
Composition for the diagnosis of retinal vascular disease comprising aldolase and method for diagnosis using it
|
|
US6743436B1
|
|
Anesthetic composition for intravenous injection comprising propofol
|
|
AU4934299A
|
|
Novel water soluble-cyclosporine conjugated compounds
|
